查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1860006

阿莫西林：全球市場佔有率和排名、總收入和需求預測（2025-2031 年）

Amoxicillin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球阿莫西林市場規模估計為 49.25 億美元，預計到 2031 年將成長至 61.62 億美元，2025 年至 2031 年的複合年成長率為 3.3%。

本報告對近期關稅調整和國際戰略反制措施對阿莫西林跨境產業佈局、資本配置模式、區域經濟相互依存關係和供應鏈重組的影響進行了全面評估。

阿莫西林是一種廣泛用於治療多種細菌感染疾病的抗生素，包括中耳炎、鏈球菌咽頭炎、肺炎、皮膚感染疾病和尿道感染感染。它通常口服給藥，注射給藥相對較少。本文討論了阿莫西林的製劑。預計到2024年，全球阿莫西林產量將達到約28.97億片，全球平均市場價格約為每片1.7美元。

阿莫西林市場機會源於全球基層醫療體系的擴張以及對可及且經濟有效的抗生素的持續需求。各國政府和國際衛生組織針對基層醫療和小兒科機構常見感染疾病管理的指南，有助於維持阿莫西林作為優先用藥的地位，並支持醫保報銷目標的實現，從而保障可預測的採購和分銷。此外，人口老化和慢性合併感染疾病的管理正在推動醫院和門診機構抗生素使用量的增加，為生產商創造了維持市場規模和品牌知名度的機會。儘管需求穩定，阿莫西林市場仍面臨許多風險，包括抗生素管理壓力、藥品短缺以及健保報銷體系帶來的價格限制。各國收緊處方法規可能會抑制不必要的藥物消費。此外，原料藥（API）和關鍵中間體的供應商集中度、不斷上升的合規成本以及全球供應鏈的波動性都威脅著供應的穩定性和盈利能力。企業需要在確保合規性和品質的同時，靈活應對政策和供應方面的系統性風險。下游需求正從傳統的醫院處方轉向社區醫療、小兒科和線上處方管道，隨著醫保報銷範圍的擴大和基層醫療的加強，口服產品的需求也日益強勁。同時，複方製劑和改良劑型（例如分散劑和兒科製劑）提高了臨床用藥的便利性，並為差異化產品線的拓展提供了機會。在許多新興市場，基本藥物的替代和處方集調整速度將決定中短期內產品組合調整和打入市場策略的時機。

本報告旨在按地區/國家、類型和應用對全球阿莫西林市場進行全面分析，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名。

阿莫西林市場規模、估計和預測以銷售（千）和收入（百萬美元）為單位呈現，基準年為2024年，並包含2020年至2031年的歷史數據和預測數據。定量和定性分析將幫助讀者制定阿莫西林業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • GSK
  • Novartis
  • Centrient Pharma
  • Teva
  • Viatris
  • Cipla
  • NCPC
  • United Laboratories
  • Sun Pharma
  • CSPC
  • LKPC
  • Hikma
  • Dr. Reddy
  • HPGC
  • Aurubindo
  • Meiji Holdings
  • Guangzhou Baiyunshan

按類型分類的細分市場

  • 膠囊
  • 藥片
  • 其他

應用領域

  • 醫院藥房
  • 零售藥房
  • 網路藥房

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Amoxicillin was estimated to be worth US$ 4925 million in 2024 and is forecast to a readjusted size of US$ 6162 million by 2031 with a CAGR of 3.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Amoxicillin cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection. In this article, we study the amoxicillin drug. In 2024, global Amoxicillin production reached approximately 2897 m units, with an average global market price of around US$ 1.7 perunit.

Amoxicillin's market opportunity is rooted in the expansion of primary healthcare systems globally and the persistent need for accessible, cost-effective antibiotics. Guidance from governments and international health bodies on managing common infections in primary care and pediatrics helps keep amoxicillin as a preferred listed medicine and within reimbursement schemes, supporting predictable procurement and distribution. Additionally, population aging and the management of chronic comorbid infections broaden antibiotic use across hospitals and outpatient settings, creating sustained market space and opportunities for manufacturers to build brand recognition.Despite steady demand, the amoxicillin market faces multiple risks including antimicrobial stewardship pressures, drug shortages, and pricing constraints from reimbursement systems. Stewardship policies tightening prescriptions in various countries can reduce unnecessary consumption; moreover, the concentration of suppliers for active pharmaceutical ingredients (APIs) and key intermediates, rising compliance costs, and global supply-chain volatility all threaten supply stability and margin profiles. Companies must balance compliance and quality with agile responses to policy and supply-side systemic risks. Downstream demand is evolving from traditional hospital prescriptions toward community healthcare, pediatrics, and online prescription channels, with reimbursement expansion and strengthened primary care capacity underpinning robust demand for oral formulations. At the same time, combination products and improved dosage forms (e.g., dispersible or child-friendly formulations) increase clinical convenience and present product-line extension opportunities for differentiation. In many emerging markets, the pace of essential-medicine substitution and formulary updates will determine the tempo of short-to-medium-term product mix adjustments and market entry strategies.

This report aims to provide a comprehensive presentation of the global market for Amoxicillin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Amoxicillin by region & country, by Type, and by Application.

The Amoxicillin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amoxicillin.

Market Segmentation

By Company

  • GSK
  • Novartis
  • Centrient Pharma
  • Teva
  • Viatris
  • Cipla
  • NCPC
  • United Laboratories
  • Sun Pharma
  • CSPC
  • LKPC
  • Hikma
  • Dr. Reddy
  • HPGC
  • Aurubindo
  • Meiji Holdings
  • Guangzhou Baiyunshan

Segment by Type

  • Capsule
  • Tablet
  • Others

Segment by Application

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Amoxicillin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Amoxicillin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Amoxicillin Product Introduction
  • 1.2 Global Amoxicillin Market Size Forecast
    • 1.2.1 Global Amoxicillin Sales Value (2020-2031)
    • 1.2.2 Global Amoxicillin Sales Volume (2020-2031)
    • 1.2.3 Global Amoxicillin Sales Price (2020-2031)
  • 1.3 Amoxicillin Market Trends & Drivers
    • 1.3.1 Amoxicillin Industry Trends
    • 1.3.2 Amoxicillin Market Drivers & Opportunity
    • 1.3.3 Amoxicillin Market Challenges
    • 1.3.4 Amoxicillin Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Amoxicillin Players Revenue Ranking (2024)
  • 2.2 Global Amoxicillin Revenue by Company (2020-2025)
  • 2.3 Global Amoxicillin Players Sales Volume Ranking (2024)
  • 2.4 Global Amoxicillin Sales Volume by Company Players (2020-2025)
  • 2.5 Global Amoxicillin Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Amoxicillin Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Amoxicillin Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Amoxicillin
  • 2.9 Amoxicillin Market Competitive Analysis
    • 2.9.1 Amoxicillin Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Amoxicillin Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amoxicillin as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Capsule
    • 3.1.2 Tablet
    • 3.1.3 Others
  • 3.2 Global Amoxicillin Sales Value by Type
    • 3.2.1 Global Amoxicillin Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Amoxicillin Sales Value, by Type (2020-2031)
    • 3.2.3 Global Amoxicillin Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Amoxicillin Sales Volume by Type
    • 3.3.1 Global Amoxicillin Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Amoxicillin Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Amoxicillin Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Amoxicillin Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospital Pharmacy
    • 4.1.2 Retail Pharmacy
    • 4.1.3 Online Pharmacy
  • 4.2 Global Amoxicillin Sales Value by Application
    • 4.2.1 Global Amoxicillin Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Amoxicillin Sales Value, by Application (2020-2031)
    • 4.2.3 Global Amoxicillin Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Amoxicillin Sales Volume by Application
    • 4.3.1 Global Amoxicillin Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Amoxicillin Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Amoxicillin Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Amoxicillin Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Amoxicillin Sales Value by Region
    • 5.1.1 Global Amoxicillin Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Amoxicillin Sales Value by Region (2020-2025)
    • 5.1.3 Global Amoxicillin Sales Value by Region (2026-2031)
    • 5.1.4 Global Amoxicillin Sales Value by Region (%), (2020-2031)
  • 5.2 Global Amoxicillin Sales Volume by Region
    • 5.2.1 Global Amoxicillin Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Amoxicillin Sales Volume by Region (2020-2025)
    • 5.2.3 Global Amoxicillin Sales Volume by Region (2026-2031)
    • 5.2.4 Global Amoxicillin Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Amoxicillin Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Amoxicillin Sales Value, 2020-2031
    • 5.4.2 North America Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Amoxicillin Sales Value, 2020-2031
    • 5.5.2 Europe Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Amoxicillin Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Amoxicillin Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Amoxicillin Sales Value, 2020-2031
    • 5.7.2 South America Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Amoxicillin Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Amoxicillin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Amoxicillin Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Amoxicillin Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Amoxicillin Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Amoxicillin Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Amoxicillin Sales Value, 2020-2031
    • 6.3.2 United States Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Amoxicillin Sales Value, 2020-2031
    • 6.4.2 Europe Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Amoxicillin Sales Value, 2020-2031
    • 6.5.2 China Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Amoxicillin Sales Value, 2020-2031
    • 6.6.2 Japan Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Amoxicillin Sales Value, 2020-2031
    • 6.7.2 South Korea Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Amoxicillin Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Amoxicillin Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Amoxicillin Sales Value, 2020-2031
    • 6.9.2 India Amoxicillin Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Amoxicillin Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 GSK
    • 7.1.1 GSK Company Information
    • 7.1.2 GSK Introduction and Business Overview
    • 7.1.3 GSK Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 GSK Amoxicillin Product Offerings
    • 7.1.5 GSK Recent Development
  • 7.2 Novartis
    • 7.2.1 Novartis Company Information
    • 7.2.2 Novartis Introduction and Business Overview
    • 7.2.3 Novartis Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Novartis Amoxicillin Product Offerings
    • 7.2.5 Novartis Recent Development
  • 7.3 Centrient Pharma
    • 7.3.1 Centrient Pharma Company Information
    • 7.3.2 Centrient Pharma Introduction and Business Overview
    • 7.3.3 Centrient Pharma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Centrient Pharma Amoxicillin Product Offerings
    • 7.3.5 Centrient Pharma Recent Development
  • 7.4 Teva
    • 7.4.1 Teva Company Information
    • 7.4.2 Teva Introduction and Business Overview
    • 7.4.3 Teva Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Teva Amoxicillin Product Offerings
    • 7.4.5 Teva Recent Development
  • 7.5 Viatris
    • 7.5.1 Viatris Company Information
    • 7.5.2 Viatris Introduction and Business Overview
    • 7.5.3 Viatris Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Viatris Amoxicillin Product Offerings
    • 7.5.5 Viatris Recent Development
  • 7.6 Cipla
    • 7.6.1 Cipla Company Information
    • 7.6.2 Cipla Introduction and Business Overview
    • 7.6.3 Cipla Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Cipla Amoxicillin Product Offerings
    • 7.6.5 Cipla Recent Development
  • 7.7 NCPC
    • 7.7.1 NCPC Company Information
    • 7.7.2 NCPC Introduction and Business Overview
    • 7.7.3 NCPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 NCPC Amoxicillin Product Offerings
    • 7.7.5 NCPC Recent Development
  • 7.8 United Laboratories
    • 7.8.1 United Laboratories Company Information
    • 7.8.2 United Laboratories Introduction and Business Overview
    • 7.8.3 United Laboratories Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 United Laboratories Amoxicillin Product Offerings
    • 7.8.5 United Laboratories Recent Development
  • 7.9 Sun Pharma
    • 7.9.1 Sun Pharma Company Information
    • 7.9.2 Sun Pharma Introduction and Business Overview
    • 7.9.3 Sun Pharma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Sun Pharma Amoxicillin Product Offerings
    • 7.9.5 Sun Pharma Recent Development
  • 7.10 CSPC
    • 7.10.1 CSPC Company Information
    • 7.10.2 CSPC Introduction and Business Overview
    • 7.10.3 CSPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 CSPC Amoxicillin Product Offerings
    • 7.10.5 CSPC Recent Development
  • 7.11 LKPC
    • 7.11.1 LKPC Company Information
    • 7.11.2 LKPC Introduction and Business Overview
    • 7.11.3 LKPC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 LKPC Amoxicillin Product Offerings
    • 7.11.5 LKPC Recent Development
  • 7.12 Hikma
    • 7.12.1 Hikma Company Information
    • 7.12.2 Hikma Introduction and Business Overview
    • 7.12.3 Hikma Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Hikma Amoxicillin Product Offerings
    • 7.12.5 Hikma Recent Development
  • 7.13 Dr. Reddy
    • 7.13.1 Dr. Reddy Company Information
    • 7.13.2 Dr. Reddy Introduction and Business Overview
    • 7.13.3 Dr. Reddy Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Dr. Reddy Amoxicillin Product Offerings
    • 7.13.5 Dr. Reddy Recent Development
  • 7.14 HPGC
    • 7.14.1 HPGC Company Information
    • 7.14.2 HPGC Introduction and Business Overview
    • 7.14.3 HPGC Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 HPGC Amoxicillin Product Offerings
    • 7.14.5 HPGC Recent Development
  • 7.15 Aurubindo
    • 7.15.1 Aurubindo Company Information
    • 7.15.2 Aurubindo Introduction and Business Overview
    • 7.15.3 Aurubindo Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Aurubindo Amoxicillin Product Offerings
    • 7.15.5 Aurubindo Recent Development
  • 7.16 Meiji Holdings
    • 7.16.1 Meiji Holdings Company Information
    • 7.16.2 Meiji Holdings Introduction and Business Overview
    • 7.16.3 Meiji Holdings Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Meiji Holdings Amoxicillin Product Offerings
    • 7.16.5 Meiji Holdings Recent Development
  • 7.17 Guangzhou Baiyunshan
    • 7.17.1 Guangzhou Baiyunshan Company Information
    • 7.17.2 Guangzhou Baiyunshan Introduction and Business Overview
    • 7.17.3 Guangzhou Baiyunshan Amoxicillin Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Guangzhou Baiyunshan Amoxicillin Product Offerings
    • 7.17.5 Guangzhou Baiyunshan Recent Development

8 Industry Chain Analysis

  • 8.1 Amoxicillin Industrial Chain
  • 8.2 Amoxicillin Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Amoxicillin Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Amoxicillin Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Amoxicillin Market Trends
  • Table 2. Amoxicillin Market Drivers & Opportunity
  • Table 3. Amoxicillin Market Challenges
  • Table 4. Amoxicillin Market Restraints
  • Table 5. Global Amoxicillin Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Amoxicillin Revenue Market Share by Company (2020-2025)
  • Table 7. Global Amoxicillin Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Amoxicillin Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Amoxicillin Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Amoxicillin Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Amoxicillin Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Amoxicillin
  • Table 13. Global Amoxicillin Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amoxicillin as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Amoxicillin Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Amoxicillin Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Amoxicillin Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Amoxicillin Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Amoxicillin Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Amoxicillin Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Amoxicillin Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Amoxicillin Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Amoxicillin Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Amoxicillin Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Amoxicillin Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Amoxicillin Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Amoxicillin Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Amoxicillin Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Amoxicillin Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Amoxicillin Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Amoxicillin Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Amoxicillin Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Amoxicillin Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Amoxicillin Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Amoxicillin Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Amoxicillin Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Amoxicillin Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Amoxicillin Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Amoxicillin Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Amoxicillin Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Amoxicillin Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Amoxicillin Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Amoxicillin Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Amoxicillin Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Amoxicillin Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Amoxicillin Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Amoxicillin Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Amoxicillin Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Amoxicillin Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Amoxicillin Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Amoxicillin Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Amoxicillin Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Amoxicillin Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Amoxicillin Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Amoxicillin Sales Volume, (2026-2031) & (K Units)
  • Table 57. GSK Company Information
  • Table 58. GSK Introduction and Business Overview
  • Table 59. GSK Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. GSK Amoxicillin Product Offerings
  • Table 61. GSK Recent Development
  • Table 62. Novartis Company Information
  • Table 63. Novartis Introduction and Business Overview
  • Table 64. Novartis Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Novartis Amoxicillin Product Offerings
  • Table 66. Novartis Recent Development
  • Table 67. Centrient Pharma Company Information
  • Table 68. Centrient Pharma Introduction and Business Overview
  • Table 69. Centrient Pharma Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Centrient Pharma Amoxicillin Product Offerings
  • Table 71. Centrient Pharma Recent Development
  • Table 72. Teva Company Information
  • Table 73. Teva Introduction and Business Overview
  • Table 74. Teva Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Teva Amoxicillin Product Offerings
  • Table 76. Teva Recent Development
  • Table 77. Viatris Company Information
  • Table 78. Viatris Introduction and Business Overview
  • Table 79. Viatris Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Viatris Amoxicillin Product Offerings
  • Table 81. Viatris Recent Development
  • Table 82. Cipla Company Information
  • Table 83. Cipla Introduction and Business Overview
  • Table 84. Cipla Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Cipla Amoxicillin Product Offerings
  • Table 86. Cipla Recent Development
  • Table 87. NCPC Company Information
  • Table 88. NCPC Introduction and Business Overview
  • Table 89. NCPC Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. NCPC Amoxicillin Product Offerings
  • Table 91. NCPC Recent Development
  • Table 92. United Laboratories Company Information
  • Table 93. United Laboratories Introduction and Business Overview
  • Table 94. United Laboratories Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. United Laboratories Amoxicillin Product Offerings
  • Table 96. United Laboratories Recent Development
  • Table 97. Sun Pharma Company Information
  • Table 98. Sun Pharma Introduction and Business Overview
  • Table 99. Sun Pharma Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. Sun Pharma Amoxicillin Product Offerings
  • Table 101. Sun Pharma Recent Development
  • Table 102. CSPC Company Information
  • Table 103. CSPC Introduction and Business Overview
  • Table 104. CSPC Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. CSPC Amoxicillin Product Offerings
  • Table 106. CSPC Recent Development
  • Table 107. LKPC Company Information
  • Table 108. LKPC Introduction and Business Overview
  • Table 109. LKPC Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. LKPC Amoxicillin Product Offerings
  • Table 111. LKPC Recent Development
  • Table 112. Hikma Company Information
  • Table 113. Hikma Introduction and Business Overview
  • Table 114. Hikma Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Hikma Amoxicillin Product Offerings
  • Table 116. Hikma Recent Development
  • Table 117. Dr. Reddy Company Information
  • Table 118. Dr. Reddy Introduction and Business Overview
  • Table 119. Dr. Reddy Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 120. Dr. Reddy Amoxicillin Product Offerings
  • Table 121. Dr. Reddy Recent Development
  • Table 122. HPGC Company Information
  • Table 123. HPGC Introduction and Business Overview
  • Table 124. HPGC Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 125. HPGC Amoxicillin Product Offerings
  • Table 126. HPGC Recent Development
  • Table 127. Aurubindo Company Information
  • Table 128. Aurubindo Introduction and Business Overview
  • Table 129. Aurubindo Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 130. Aurubindo Amoxicillin Product Offerings
  • Table 131. Aurubindo Recent Development
  • Table 132. Meiji Holdings Company Information
  • Table 133. Meiji Holdings Introduction and Business Overview
  • Table 134. Meiji Holdings Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 135. Meiji Holdings Amoxicillin Product Offerings
  • Table 136. Meiji Holdings Recent Development
  • Table 137. Guangzhou Baiyunshan Company Information
  • Table 138. Guangzhou Baiyunshan Introduction and Business Overview
  • Table 139. Guangzhou Baiyunshan Amoxicillin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 140. Guangzhou Baiyunshan Amoxicillin Product Offerings
  • Table 141. Guangzhou Baiyunshan Recent Development
  • Table 142. Key Raw Materials Lists
  • Table 143. Raw Materials Key Suppliers Lists
  • Table 144. Amoxicillin Downstream Customers
  • Table 145. Amoxicillin Distributors List
  • Table 146. Research Programs/Design for This Report
  • Table 147. Key Data Information from Secondary Sources
  • Table 148. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Amoxicillin Product Picture
  • Figure 2. Global Amoxicillin Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Amoxicillin Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Amoxicillin Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Amoxicillin Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Amoxicillin Report Years Considered
  • Figure 7. Global Amoxicillin Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Amoxicillin Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Amoxicillin Revenue in 2024
  • Figure 10. Amoxicillin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Capsule Picture
  • Figure 12. Tablet Picture
  • Figure 13. Others Picture
  • Figure 14. Global Amoxicillin Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Amoxicillin Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Amoxicillin Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 17. Global Amoxicillin Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Amoxicillin Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Hospital Pharmacy
  • Figure 20. Product Picture of Retail Pharmacy
  • Figure 21. Product Picture of Online Pharmacy
  • Figure 22. Global Amoxicillin Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 23. Global Amoxicillin Sales Value Market Share by Application, 2024 & 2031
  • Figure 24. Global Amoxicillin Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 25. Global Amoxicillin Sales Volume Market Share by Application, 2024 & 2031
  • Figure 26. Global Amoxicillin Price by Application (2020-2031) & (US$/Unit)
  • Figure 27. North America Amoxicillin Sales Value (2020-2031) & (US$ Million)
  • Figure 28. North America Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • Figure 29. Europe Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 30. Europe Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • Figure 31. Asia Pacific Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. Asia Pacific Amoxicillin Sales Value by Region (%), 2024 VS 2031
  • Figure 33. South America Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 34. South America Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • Figure 35. Middle East & Africa Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 36. Middle East & Africa Amoxicillin Sales Value by Country (%), 2024 VS 2031
  • Figure 37. Key Countries/Regions Amoxicillin Sales Value (%), (2020-2031)
  • Figure 38. Key Countries/Regions Amoxicillin Sales Volume (%), (2020-2031)
  • Figure 39. United States Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 40. United States Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 41. United States Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 42. Europe Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. Europe Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 44. Europe Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 45. China Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. China Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 47. China Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 48. Japan Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. Japan Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 50. Japan Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 51. South Korea Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. South Korea Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 53. South Korea Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 54. Southeast Asia Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. Southeast Asia Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 56. Southeast Asia Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 57. India Amoxicillin Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. India Amoxicillin Sales Value by Type (%), 2024 VS 2031
  • Figure 59. India Amoxicillin Sales Value by Application (%), 2024 VS 2031
  • Figure 60. Amoxicillin Industrial Chain
  • Figure 61. Amoxicillin Manufacturing Cost Structure
  • Figure 62. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 63. Bottom-up and Top-down Approaches for This Report
  • Figure 64. Data Triangulation
  • Figure 65. Key Executives Interviewed